RESMED INC — Director's Dealing 2021

Nov 18, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2021-11-16

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-16	ResMed Common Stock	A	71262	$254.81	Acquired	487220	Direct
2021-11-17	ResMed Common Stock	F	42210	$254.81	Disposed	445010	Direct
2021-11-18	ResMed Common Stock	A	4469	—	Acquired	449479	Direct
2021-11-19	ResMed Common Stock	G	44250	—	Disposed	405229	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	8970	Indirect

Footnotes

F1: Represents performance-based restricted stock units granted on November 14, 2018. The shares were earned on November 16, 2021, when the compensation committee certified that the performance metrics were met.

F2: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/14/2018.

F3: Represents performance-based restricted stock units granted on November 19, 2020. The shares were earned on November 18, 2021, when the compensation committee certified that the performance metrics were met for this portion of the grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date.

F4: Gift of shares to the Farrell Legacy Trust. Mr. Farrell has no beneficial interest, control or dispositive power over the gifted shares.